Literature DB >> 15133854

Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98.

Chao-Yang Lou1, Ying-Ming Feng, Ai-Rong Qian, Yu Li, Hao Tang, Peng Shang, Zhi-Nan Chen.   

Abstract

AIM: To establish a novel human hepatocellular carcinoma (HCC) cell line FHCC-98 from HCC tissue and to provide a suitable model for studying HCC occurrence, progress and metastasis.
METHODS: Serially passaged cells were cultured and their morphologies were observed under light and electron microscope. Cytogenetic study was conducted by using flow cytometry and chromosome analysis. Expressions of tumor markers such as alpha-fetoprotein (AFP), cytokeratin (CK) and hepatoma metastasis-associated factor HAb18G/CD147 on the FHCC-98 cells were detected by immunocytochemistry or Western blotting. Lactic dehydrogenase (LDH) isoenzymes were detected by polyacrylamide gel electrophoresis (PAGE). Xenograft was performed by inoculating FHCC-98 cells into the flanks of nude mice.
RESULTS: Morphology of FHCC-98 cells was the same as that of other malignant cells. The expressions of the cells were positive for HAb18G/CD147 and CK, and negative for AFP. Its population doubling time was 21.4 h. The cell DNA was tetraploid and the major chromosomes were triploid by cytogenetics analysis. The tumorigenicity in nude mice was 100%. PAGE showed four bands representing LDH2, LDH3, LDH4 and LDH5.
CONCLUSION: FHCC-98 is a novel HCC cell line and an ideal cell model for further exploring the mechanism of hepatocellular carcinoma invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133854      PMCID: PMC4656285          DOI: 10.3748/wjg.v10.i10.1462

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Indications and results of resection for hepatocellular carcinoma.

Authors:  V Ziparo; G Balducci; G Lucandri; P Mercantini; G Di Giacomo; E Fernandes
Journal:  Eur J Surg Oncol       Date:  2002-11       Impact factor: 4.424

2.  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.

Authors:  Y Li; Z Y Tang; S L Ye; Y K Liu; J Chen; Q Xue; J Chen; D M Gao; W H Bao
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  [Establishment of a cisplatin-induced human hepatocellular carcinoma drug-resistant cell line and its biological characteristics].

Authors:  Jun-xia Yang; Wei-xue Tang
Journal:  Ai Zheng       Date:  2002-08

4.  Establishment and characteristics of human hepatocellular carcinoma cells with metastasis to lymph nodes.

Authors:  S Seki; T Kitada; N Kawada; H Sakaguchi; H Kadoya; K Nakatani; K Satake; T Kuroki
Journal:  Hepatogastroenterology       Date:  1999 Sep-Oct

Review 5.  Liver cancer.

Authors:  A Aguayo; Y Z Patt
Journal:  Clin Liver Dis       Date:  2001-05       Impact factor: 6.126

Review 6.  Hepatocellular carcinoma: is current therapy really altering outcome?

Authors:  P J Johnson
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  Establishment and characterization of human metastatic hepatocellular carcinoma cell line.

Authors:  Jian Ming Wen; Jie Fu Huang; Liang Hu; Wei Sheng Wang; Meng Zhang; Jonathan S T Sham; Jian Min Xu; Wei Fen Zeng; Dan Xie; Li Jian Liang; Xin Yuan Guan
Journal:  Cancer Genet Cytogenet       Date:  2002-05

8.  Analysis of sex, age and disease factors contributing to prolonged life expectancy at birth, in cases of malignant neoplasms in Japan.

Authors:  Tomoyuki Watanabe; Masako Omori; Hiromi Fukuda; Hiroki Takada; Masaru Miyao; Yutaka Mizuno; Isao Ohsawa; Yuzo Sato; Toshihiko Hasegawa
Journal:  J Epidemiol       Date:  2003-05       Impact factor: 3.211

9.  Genomic imbalances in Korean hepatocellular carcinoma.

Authors:  Gi-Jin Kim; Seong-Jin Cho; Nam-Hee Won; Jin-Mo Sung; Hyun Kim; Yong-Hyuck Chun; Sun-Hwa Park
Journal:  Cancer Genet Cytogenet       Date:  2003-04-15

10.  trans-Acting factors, detoxication enzymes and hepatitis B virus replication in a novel set of human hepatoma cell lines.

Authors:  C Le Jossic; D Glaise; L Corcos; C Diot; J F Dezier; A Fautrel; C Guguen-Guillouzo
Journal:  Eur J Biochem       Date:  1996-06-01
View more
  5 in total

1.  Heparin promotes suspension adaptation process of CHO-TS28 cells by eliminating cell aggregation.

Authors:  Ling Li; Jun Qin; Qiang Feng; Hao Tang; Rong Liu; Liqing Xu; Zhinan Chen
Journal:  Mol Biotechnol       Date:  2011-01       Impact factor: 2.695

2.  Circular dorsal ruffles disturb the growth factor-induced PI3K-AKT pathway in hepatocellular carcinoma Hep3B cells.

Authors:  Xiaowei Sun; Yujie Liu; Shuheng Zhou; Li Wang; Jinzi Wei; Rui Hua; Zhongyang Shen; Sei Yoshida
Journal:  Cell Commun Signal       Date:  2022-07-07       Impact factor: 7.525

Review 3.  Experimental models of hepatocellular carcinoma: developments and evolution.

Authors:  Long Wu; Zhao-You Tang; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-28       Impact factor: 4.553

4.  Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma.

Authors:  Yeonhwa Song; Jin-Sun Kim; Se-Hyuk Kim; Yoon Kyung Park; Eunsil Yu; Ki-Hun Kim; Eul-Ju Seo; Heung-Bum Oh; Han Chu Lee; Kang Mo Kim; Haeng Ran Seo
Journal:  J Exp Clin Cancer Res       Date:  2018-05-25

5.  Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cm.

Authors:  Hae-Na Shin; Shin Hwang; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Young-Joo Lee; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2013-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.